GL Pharmatech Acquires Additional 2 Billion KRW Worth of Shares in Subsidiary GL Pharma

[Asia Economy Reporter Kim Heung-soon] GL Pharmatech announced on the 28th that it will additionally acquire 66,667 shares of its pharmaceutical manufacturing subsidiary GL Pharma for approximately 2 billion KRW. After the stock acquisition, GL Pharmatech's stake in GL Pharma will reach 100%. The scheduled date for the stock acquisition is the same day as the announcement. The company stated that the purpose of this stock acquisition is "operating funds and facility investment funds."

This content was produced with the assistance of AI translation services.